Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line

Cancer Chemotherapy and Pharmacology
Y S SonI K Chung

Abstract

A human stomach-adenocarcinoma cell line (MKN-45) was selected for resistance to Adriamycin by stepwise exposure to increasing concentrations of this agent. The resulting cell line (MKN/ADR) exhibited a high level of cross-resistance to topoisomerase II (topo II)-targeted drugs such as Adriamycin, mitoxantrone, and etoposide but showed no cross-resistance to other chemotherapeutic agents such as cisplatin, carboplatin, 5-fluorouracil, or mitomycin-C. P-glycoprotein encoded by the mdr-1 gene was not overexpressed in the MKN/ADR cell line. The doubling time of the MKN/ADR cell line (2.1 days) increased only slightly as compared with that of the MKN cell line (1.7 days). The patterns of cross-resistance to various chemotherapeutic agents led us to examine the cellular contents of topo II in both the drug-sensitive and the drug-resistant cells. Extractable topo II enzyme activity was 3-fold lower in MKN/ADR cells as compared with the parental MKN cells. Levels of topoisomerase I (topo I) catalytic activity were similar in both wild-type MKN and drug-resistant MKN/ADR cells. Southern-blot analysis of genomic DNA probed with topo IIalpha or IIbeta showed no sign of either gene rearrangement or hypermethylation. Northern-blot analysis...Continue Reading

Citations

Apr 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xianke ZengDouglas Yee
Aug 3, 2014·Research in Veterinary Science·Joseph HillRobert Gogal
Aug 25, 2004·The Journal of Pharmacy and Pharmacology·M SawickaW Lewandowski
Mar 19, 2016·The Journal of Pharmacy and Pharmacology·Ann-Marie Meredith, Crispin R Dass
Jul 26, 2016·Frontiers in Oncology·Leonardo Marques da FonsecaMárcia Alves Marques Capella
May 28, 2011·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Evgenia LampropoulouEvangelia Papadimitriou
Feb 2, 2006·International Journal of Cancer. Journal International Du Cancer·Hermann LageIsmail Yalcin
Aug 15, 2000·The Journal of Biological Chemistry·M P BolandL A O'Neill
Feb 8, 2002·World Journal of Gastroenterology : WJG·Xin WangDai-Ming Fan
Mar 19, 2020·OncoTargets and Therapy·Tuo RuanChuanqing Wu
Aug 11, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·William T. BeckUppoor G. Bhat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.